Synopsys, Inc. $SNPS Shares Acquired by Generali Investments Management Co LLC

Generali Investments Management Co LLC lifted its stake in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 275.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,163 shares of the semiconductor company’s stock after buying an additional 2,321 shares during the period. Generali Investments Management Co LLC’s holdings in Synopsys were worth $1,561,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Alpine Bank Wealth Management grew its stake in Synopsys by 89.3% during the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock valued at $26,000 after purchasing an additional 25 shares in the last quarter. TFC Financial Management Inc. raised its position in shares of Synopsys by 1,250.0% in the 3rd quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock valued at $27,000 after purchasing an additional 50 shares in the last quarter. Millstone Evans Group LLC purchased a new position in shares of Synopsys during the 3rd quarter valued at approximately $27,000. SOA Wealth Advisors LLC. acquired a new stake in shares of Synopsys during the third quarter worth approximately $28,000. Finally, McIlrath & Eck LLC bought a new stake in shares of Synopsys in the third quarter worth $29,000. Institutional investors and hedge funds own 85.47% of the company’s stock.

Insider Activity

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the sale, the chief financial officer directly owned 17,842 shares in the company, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Janet Lee sold 250 shares of the firm’s stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the transaction, the insider owned 11,959 shares of the company’s stock, valued at approximately $6,338,270. This trade represents a 2.05% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 4,157 shares of company stock worth $1,945,036. 0.62% of the stock is owned by company insiders.

Key Stories Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

  • Positive Sentiment: Q1 beat on revenue and EPS; Synopsys reported $2.41B revenue (up ~65%) and $3.77 non‑GAAP EPS, topping estimates and raising FY‑2026 EPS guidance — a core fundamental positive that supports longer‑term growth expectations. Article Title
  • Positive Sentiment: Board approved a $2.0B replenishment to the share repurchase program — a near‑term capital return that can support the stock and offset some selling pressure. Article Title
  • Positive Sentiment: Unusual options/whale activity — heavy call buying was reported, signaling speculative bullish interest from traders and possible hedged purchases by institutions. Article Title Article Title
  • Neutral Sentiment: Analyst consensus remains tilted toward Buy despite some downgrades — the average brokerage rating is still positive, leaving a mixed sell‑side backdrop rather than a broad rout. Article Title
  • Neutral Sentiment: Long‑term thesis intact: Market commentary highlights Synopsys’ dominant EDA position, potential Ansys synergies over several years, and institutional interest (including Nvidia exposure), which supports a multi‑year growth story even as near‑term noise persists. Article Title
  • Negative Sentiment: Guidance and China export risks weighed on shares — management’s Q2 revenue commentary and Reuters reports about China export restrictions created a muted outlook that disappointed some investors despite the beat. Article Title
  • Negative Sentiment: Analysts trimmed price targets and ratings after the print — several firms cut targets (Wells Fargo, Piper Sandler, Rosenblatt adjustments noted), increasing short‑term downside risk from reduced upside to current levels. Article Title
  • Negative Sentiment: Ansys acquisition and integration costs remain a near‑term drag: GAAP impact, additional debt load and workforce actions are pressuring margins even as management targets multi‑year synergies — investors are pricing in execution risk. Article Title

Analyst Ratings Changes

SNPS has been the topic of several recent analyst reports. JPMorgan Chase & Co. upped their price target on shares of Synopsys from $600.00 to $650.00 and gave the company an “overweight” rating in a report on Thursday, December 11th. Morgan Stanley restated an “overweight” rating on shares of Synopsys in a research note on Wednesday. Zacks Research upgraded Synopsys from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. The Goldman Sachs Group set a $600.00 price objective on Synopsys and gave the company a “buy” rating in a report on Wednesday. Finally, Wall Street Zen upgraded Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Nine research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $535.67.

Check Out Our Latest Research Report on SNPS

Synopsys Stock Performance

Shares of SNPS stock opened at $426.00 on Friday. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $651.73. The firm has a market capitalization of $81.60 billion, a price-to-earnings ratio of 66.15, a price-to-earnings-growth ratio of 3.74 and a beta of 1.12. The business has a 50 day simple moving average of $472.21 and a 200 day simple moving average of $478.66. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52.

Synopsys (NASDAQ:SNPSGet Free Report) last issued its quarterly earnings data on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share for the quarter, beating analysts’ consensus estimates of $3.56 by $0.21. The business had revenue of $2.41 billion for the quarter, compared to analysts’ expectations of $2.39 billion. Synopsys had a net margin of 13.76% and a return on equity of 7.49%. The company’s revenue was up 65.6% on a year-over-year basis. During the same period in the previous year, the business earned $3.03 earnings per share. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. On average, equities research analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current year.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Articles

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.